EMPERY ASSET MANAGEMENT, LP – Lixte Biotechnology Holdings, Inc. Transaction History
EMPERY ASSET MANAGEMENT, LP portfolio value:
$0
portfolio value
EMPERY ASSET MANAGEMENT, LP quarter portfolio value change:
-23.94%
quarter
Lixte Biotechnology Holdings, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -99.83K shares | -12K | $0.09 | 0 |
| Q2 2022 | share | Decrease | -5.16% | -5.42K shares | -8K | $0.12 | 99.83K |
| Q1 2022 | share | Increase | 0.00% | 105.26K shares | 20K | $0.19 | 105.26K |